Search Results
(±)19(20)-DiHDTE 25 µg | ≥98%
Cayman Chemical
(±)19(20)-DiHDTE
(±)19(20)-EDP Ethanolamide 500 µg | ≥98%
Cayman Chemical
(±)19(20)-EDP Ethanolamide
(±)19(20)-EDP Ethanolamide 100 µg | ≥98%
Cayman Chemical
(±)19(20)-EDP Ethanolamide
(±)19(20)-EDP Ethanolamide 50 µg | ≥98%
Cayman Chemical
(±)19(20)-EDP Ethanolamide
(±)19(20)-EDP Ethanolamide 25 µg | ≥98%
Cayman Chemical
(±)19(20)-EDP Ethanolamide
(±)19(20)-EDP Ethanolamide 1 mg | Purity Not Available
TargetMol
(±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively). It is produced through direct epoxygenation of docosahexaenoyl ethanolamide by cytochrome P450 (CYP) epoxygenases. (±)19(20)-EDP ethanolamide (25 μM) reduces the viability of 143B metastatic osteosarcoma cells. It decreases the production of IL-6 […]
More Information Supplier Page(±)19(20)-EpDPA 500 µg | ≥98%
Cayman Chemical
(±)19(20)-EpDPA
(±)19(20)-EpDPA 100 µg | ≥98%
Cayman Chemical
(±)19(20)-EpDPA
(±)19(20)-EpDPA 50 µg | ≥98%
Cayman Chemical
(±)19(20)-EpDPA
(±)19(20)-EpDPA 25 µg | ≥98%
Cayman Chemical
(±)19(20)-EpDPA